U M D C Diabetes Research is categorized under Endocrinologists in Miami, FL and active since 1994.
U M D C Diabetes Research was established in 1994, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Luigi Meneghini at the company’s single location by writing to 1450 Nw 10th Avenue, Miami, Florida FL 33136 or by phoning (305) 243-6061. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | U M D C Diabetes Research |
| Contact Person: | Dr Luigi Meneghini |
| Address: | 1450 Nw 10th Avenue, Miami, Florida 33136 |
| Phone Number: | (305) 243-6061 |
| Website Address: | diabetesresearch.org |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Endocrinologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
U M D C Diabetes Research was started in 1994 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dr Luigi Meneghini for inquiries that concern U M D C Diabetes Research by calling the company number (305) 243-6061, as your correspondence is most welcome. Additionally, the physical location of the single location of U M D C Diabetes Research can be found at the coordinates 25.788912,-80.211206 as well as the street address 1450 Nw 10th Avenue in Miami, Florida 33136.
For its online presence, you may visit U M D C Diabetes Research’s website at diabetesresearch.org and engage with its social media outlets through on Twitter and on Facebook.